Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
20.76
+0.40 (1.96%)
At close: Nov 4, 2024, 4:00 PM
22.65
+1.89 (9.10%)
After-hours: Nov 4, 2024, 7:59 PM EST

Company Description

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.

The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.

In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category.

Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners.

Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc.
Hims & Hers Health logo
Country United States
Founded 2017
Industry Household & Personal Products
Sector Consumer Staples
Employees 1,046
CEO Andrew Dudum

Contact Details

Address:
2269 Chestnut Street, Suite 523
San Francisco, California 94123
United States
Phone 415 851 0195
Website forhims.com

Stock Details

Ticker Symbol HIMS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001773751
CUSIP Number 433000106
ISIN Number US4330001060
SIC Code 8011

Key Executives

Name Position
Andrew Dudum Co-Founder, Chairman and Chief Executive Officer
Yemi Okupe Chief Financial Officer
Melissa Baird Chief Operating Officer
Soleil Teubner Boughton Chief Legal Officer and Corporate Secretary
Dr. Patrick Carroll M.D. Chief Medical Officer, Member of Medical Advisory Board and Director
Mike Chi Chief Commercial Officer
Irene A. Becklund Senior Vice President, Controller and Principal Accounting Officer
Khobi Brooklyn Chief Communications Officer
Amee Parekh Senior Vice President of Human Resources
Dr. Peter Stahl M.D. Senior Vice President and Member of Medical Advisory Board

Latest SEC Filings

Date Type Title
Nov 4, 2024 10-Q Quarterly Report
Nov 4, 2024 8-K Current Report
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 29, 2024 144 Filing
Oct 25, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Oct 25, 2024 144 Filing
Oct 22, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 21, 2024 144 Filing
Oct 16, 2024 144 Filing